Skip to main content

Walleye Capital LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1758720 NEW YORK, NY

Position in ESPR

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
3,031
-99.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
11,900
PutValue
$0
PutShares
14,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Walleye Capital LLC holds $47,294,180 across 23 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 14,600
2026-03-31 11,900
2026-03-31 3,031
2025-12-31 1,569,216
2025-12-31 159,700
2025-12-31 176,300
2025-09-30 72,800
2025-09-30 319,191
2025-09-30 20,100
2024-12-31 8,700
2024-12-31 80,837
2024-12-31 18,900
2024-03-31 227,630
2023-12-31 214,000
2023-03-31 500
2023-03-31 6,300
2023-03-31 12,296
2022-09-30 698,343
2022-09-30 10,800
2022-09-30 13,800
2022-06-30 724,454
2022-03-31 306,681
2021-12-31 160,749